The estimated Net Worth of Gajus Vincent Worthington is at least $8.07 Milion dollars as of 22 August 2016. Gajus Worthington owns over 3,247 units of Standard BioTools Inc stock worth over $54,760 and over the last 14 years Gajus sold FLDM stock worth over $8,019,202.
Gajus has made over 52 trades of the Standard BioTools Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Gajus exercised 3,247 units of FLDM stock worth $12,046 on 22 August 2016.
The largest trade Gajus's ever made was selling 36,000 units of Standard BioTools Inc stock on 14 November 2013 worth over $1,080,000. On average, Gajus trades about 6,890 units every 25 days since 2011. As of 22 August 2016 Gajus still owns at least 14,760 units of Standard BioTools Inc stock.
You can see the complete history of Gajus Worthington stock trades at the bottom of the page.
Gajus's mailing address filed with the SEC is FLUIDIGM CORPORATION, 7000 SHORELINE COURT, SUITE 100, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... a Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: